What is the translation of " PARALLEL EXPORTS " in Slovenian?

• vzporedni izvoz

Examples of using Parallel exports in English and their translations into Slovenian

Competition- Community rules- Scope ratione materiae- Practices aimed at preventing or restricting parallel exports- Included.
Konkurenca- Pravila Skupnosti- Vsebinsko področje uporabe- Praksa, s katero se poskuša prepovedati ali omejiti vzporedni izvoz- Vključitev.

In that connection, such an undertaking cannot rely on the fact that the parallel exports which it seeks to limit are of only minimal benefit to the final consumers.
Glede tega se tako podjetje ne more opreti na dejstvo, da ima vzporedni izvoz, ki ga sku�a omejiti, le majhno korist za končnega potro�nika.

(Article 82 EC- Abuse of dominant position- Pharmaceutical products- Refusal to supply wholesalers engaging in parallel exports- Ordinary orders).
Člen 82 ES- Zloraba prevladujočega položaja- Farmacevtski proizvodi- Zavrnitev oskrbe trgovcem na debelo, ki opravljajo vzporedni izvoz- Običajna naročila“.

In that connection, it should be noted that parallel exports of medicinal products from a Member State where the prices are low to other Member States in which the.
V zvezi s tem je treba omeniti, da vzporedni izvoz zdravil iz države članice, v kateri so cene teh zdravil nizke, v države članice, v katerih so cene vi�je.

LÉLOS KAI SIA AND OTHERS account of the fact that those wholesalers are involved in parallel exports of those products to other Member States.
LÉLOS KAI SIA IN DRUGI izpolnjevanje naročil, ki ji jih po�iljajo trgovci na debelo, ker so ti trgovci dejavni pri vzporednem izvozu teh zdravil v druge države članice.

Parallel exports of medicinal products from a Member State where the prices are low to other Member States in which the prices are higher open up in principle an alternative source of supply to buyers of the medicinal products in those latter States, which necessarily brings some benefits to the final consumer of those products.
Vzporedni izvoz zdravil iz države članice, v kateri so cene teh zdravil nizke, v države članice, v katerih so cene vi�je, namreč načeloma kupcem teh zdravil v slednjih državah daje na voljo alternativni vir oskrbe, kar gotovo pomeni prednost za končnega potro�nika teh zdravil.

Not even GSK has denied that its real aim is to eliminate the parallel exports by the wholesalers of the three medicines in dispute from Greece to other countries in the Community.
GSK ni zanikala, da je resnično želela odpraviti vzporedni izvoz treh spornih zdravil iz Grčije v druge države Skupnosti, ki ga opravljajo podjetja za trgovino na debelo.

A contractual obligation linked to a broadcasting licence requiring the broadcaster to prevent its satellite decoder cards which enable reception of the licensed programme content from being used outside the licensed territory has the same effect as agreements to prevent or restrict parallel exports.
Pogodbena obveznost, ki je povezana z licenco za oddaje, v skladu s katero mora izdajatelj televizijskih programov preprečiti, da se zunaj licenciranega ozemlja uporabljajo dekodirne satelitske kartice, ki omogočajo sprejemanje licencirane programske vsebine, ima enak učinek kot sporazumi za oviranje ali omejevanje vzporednih izvozov.

In this case it is common ground between the parties in the main proceedings that, by refusing to meet the Greek wholesalers' orders, GSK AEVE aims to limit parallel exports by those wholesalers to the markets of other Member States in which the selling prices of the medicinal products in dispute are higher.
V tem primeru med strankami v postopku v glavni stvari ni sporno, da sku�a GSK AEVE z zavrnitvijo izpolnitve naročil gr�kih trgovcev na debelo omejiti vzporedni izvoz s strani le-teh na trge drugih držav članic, v katerih je prodajna cena zadevnih zdravil vi�ja.

It is true, as GSK AEVE has pointed out, that, for medicines subject to parallel exports, the existence of price differences between the exporting and the importing Member States does not necessarily imply that the final consumer in the importing Member State will benefit from a price corresponding to the one prevailing in the exporting Member State, inasmuch as the wholesalers carrying out the exports will themselves make a profit from that parallel trade.
Res je, kot je navedla GSK AEVE, da za zdravila, ki so predmet vzporednega izvoza, obstoj cenovnih razlik med državami članicami izvoza in državami članicami uvoza ne pomeni nujno, da bo imel končni potro�nik v državi članici uvoza koristi od cene, ki ustreza tisti v državi članici izvoza, če bodo trgovci na debelo, ki opravljajo ta izvoz, sami pridobili koristi iz navedene vzporedne trgovine.

Lélos kai Sia EE and Others v GlaxoSmithKline AEVE Farmakeftikon Proionton, formerly Glaxowellcome AEVE(Article 82 EC- Abuse of dominant position- Pharmaceutical products- Refusal to supply wholesalers engaging in parallel exports- Ordinary orders)(References for a preliminary ruling from the Efetio Athinon).
Lélos kai Sia EE in drugi proti GlaxoSmithKline AEVE Farmakeftikon Proïonton, prej Glaxowellcome AEVE(„Člen 82 ES- Zloraba prevladujočega položaja- Farmacevtski proizvodi- Zavrnitev oskrbe trgovcem na debelo, ki opravljajo vzporedni izvoz- Običajna naročila“)(Predlog za sprejetje predhodne odločbe, ki ga je vložilo Efeteio Athinon).

Article 82 EC must therefore be interpreted as meaning that an undertaking occupying a dominant position on the relevant market for medicinal products which, in order to put a stop to parallel exports carried out by certain wholesalers from one Member State to other Member States, refuses to meet ordinary orders from those wholesalers, is abusing its dominant position.
Člen 82 ES je treba torej razlagati tako, da podjetje, ki ima prevladujoči položaj na zadevnem trgu zdravil in ki- da bi preprečilo vzporedni izvoz, ki ga opravljajo nekateri trgovci na debelo iz ene države članice v druge države članice- zavrne izpolnitev običajnih naročil teh trgovcev na debelo, zlorablja svoj prevladujoči položaj.

LÉLOS KAI SIA AND OTHERS a trading party constitutes abuse in the light of the degree to which that party's activities offer advantages to the final consumers, it is clear that, in the circumstances of the main proceedings, such an undertaking cannot base its arguments on the premiss that the parallel exports which it seeks to limit are of only minimal benefit to the final consumers.
LÉLOS KAI SIA IN DRUGI pomeni zlorabo glede na stopnjo, po kateri dejavnosti slednjega ponujajo prednosti končnemu potro�niku, je treba ugotoviti, da se v okoli�činah zadeve v glavni stvari tako podjetje ne more opreti na predpostavko, da ima vzporedni izvoz, ki ga sku�a omejiti, le majhno korist za končnega potro�nika.

Thus, agreements aimed at partitioning national markets according to national borders or making the interpenetration of national markets more difficult, in particular those aimed at preventing or restricting parallel exports, have been held by the Community judicature to be agreements whose object is to restrict competition within the meaning of that article of the Treaty.
Tako je sodi�če Skupnosti sporazume, s katerimi se je sku�alo predeliti nacionalne trge po nacionalnih mejah ali otežiti prodor na nacionalne trge, predvsem tiste, s katerimi se je merilo na omejevanje vzporednega izvoza, večkrat opredelilo kot sporazume, ki imajo za cilj omejevanje konkurence v smislu navedenega člena Pogodbe.

In its written observations, GSK AEVE contends that the factors mentioned by the referring court in its questions constitute objective considerations, on the basis of which it cannot be regarded as an abuse for a pharmaceuticals company to limit supplies of medicines to the needs of a given national market when confronted with orders from wholesalers involved in parallel exports to other Member States where the selling prices of those medicines are set at a higher level.
GSK AEVE v pisnih stali�čih trdi, da so dejavniki, ki jih omenja predložitveno sodi�če v svojih vpra�anjih za predhodno odločanje, objektivni preudarki, na podlagi katerih dejstvo, da farmacevtsko podjetje omeji dobavo zdravil v skladu s potrebami danega nacionalnega trga, ne more pomeniti zlorabe, če se to podjetje srečuje z naročili trgovcev na debelo, vključenih v vzporedni izvoz v druge države članice, kjer so prodajne cene teh zdravil vi�je.

It follows that, even if the degree of regulation regarding the price of medicines cannot prevent any refusal by a pharmaceuticals company in a dominant position to meet orders sent to it by wholesalers involved in parallel exports from constituting an abuse, such a company must nevertheless be in a position to take steps that are reasonable and in proportion to the need to protect its own commercial interests.
Tako tudi če stopnja ureditve cen zdravil ne more zagotoviti, da nobena zavrnitev farmacevtskega podjetja s prevladujočim položajem, da izpolni naročila, ki so mu jih poslali trgovci na debelo, dejavni pri vzporednem izvozu, ne pomeni zlorabe, mora biti tako podjetje vseeno sposobno sprejeti ukrepe, ki so razumni in sorazmerni s potrebo po varstvu lastnih trgovskih interesov.

In this situation, GSK maintains that Member State price setting as well as the obligation to manage stocks to meet domestic demand constrain it to such an extent that the only means available to it to redress the situation from a business point of view is to make it more difficult for the Greek wholesalers to carry out parallel exports to countries where the amount reimbursed for each product far exceeds that obtainable in Greece.
V teh okoli�činah GSK trdi, da so jo zgornje meje, ki so jih določile države članice na področju cen, in obveznost upravljanja zalog, prilagojenih nacionalnemu povpra�evanju, tako omejile, da ji za normaliziranje svojih dejavnosti ni preostalo nič drugega, kot da je postavila ovire za vzporedni izvoz gr�kih trgovcev na debelo v države, v katerih zneski, povrnjeni za zdravila, zelo presegajo zneske, dosežene v Helenski republiki.

Those considerations equally deal with the argument raised by GSK AEVE, namely the impact of State regulation on the supply of medicinal products, and more par-ticularly the argument that undertakings that engage in parallel exports are not subject to the same obligations regarding distribution and warehousing as the pharmaceuticals companies and are therefore liable to disrupt the planning of production and distribution of medicines.
Ti preudarki ustrezajo tudi trditvi, na katero se sklicuje GSK AEVE glede vpliva državne ureditve v zvezi z oskrbo z zdravili, in predvsem trditvi, da za podjetja, ki opravljajo vzporedni izvoz, ne veljajo iste obveznosti distribucije in skladi�čenja, kot veljajo za farmacevtska podjetja in lahko zato zmotijo načrtovanje proizvodnje in distribucije zdravil.

Although the degree of price regulation in the pharmaceuticals sector cannot therefore preclude the Community rules on competition from applying, the fact none the less remains that, when assessing, in the case of Member States with a system of price regulation, whether the refusal of a pharmaceuticals company to supply medicines to wholesalers involved in parallel exports constitutes abuse, it cannot be ignored that such State intervention is one of the factors liable to create opportunities for parallel trade.
Čeprav stopnja ureditve cen v sektorju farmacevtskih proizvodov ne more izključiti uporabe pravil Skupnosti o konkurenci, ostaja dejstvo, da pri ocenjevanju- v primeru držav članic s sistemom ureditve cen- ali zavrnitev farmacevtskega podjetja, da dobavi zdravila trgovcem na debelo, ki so vključeni v vzporedni izvoz, pomeni zlorabo, ni mogoče spregledati, da je to državno posredovanje dejavnik, ki lahko ustvari priložnosti za vzporedno trgovino.

In view of the foregoing, the answer to the questions referred should be that Article 82 EC must be interpreted as meaning that an undertaking occupying a dominant pos-ition on the relevant market for medicinal products which, in order to put a stop to parallel exports carried out by certain wholesalers from one Member State to other Member States, refuses to meet ordinary orders from those wholesalers is abusing its dominant position.
Glede na vse navedeno je treba na postavljena vpra�anja odgovoriti, da je treba člen 82 ES razlagati tako, da podjetje, ki ima prevladujoč položaj na zadevnem trgu zdravil in ki- da bi preprečilo vzporedni izvoz, ki ga opravljajo nekateri trgovci na debelo iz ene države članice v druge države članice- zavrne izpolnitev naročil običajne narave teh trgovcev na debelo, zlorablja svoj prevladujoči položaj.

Thus on a number of occasions the Court has held agreements aimed at partitioning national markets according to national borders or making the interpenetration of national markets more difficult, in particular those aimed at preventing or restricting parallel exports, to be agreements whose object is to restrict competition within the meaning of that Treaty article.
Tako je Sodišče večkrat opredelilo sporazume, s katerimi so se skušali opredeliti nacionalni trgi po nacionalnih mejah ali otežiti prodori na nacionalne trge, predvsem tiste, s katerimi se je merilo na omejevanje vzporednega izvoza, kot sporazume, ki imajo za cilj omejevanje konkurence v smislu navedenega člena 101(1) PDEU.

It must be examined in this context whether, as GSK AEVE claims, particular circumstances are present in the pharmaceuticals sector, by reason of which the refusal by an undertaking in a dominant position to supply clients in a given Member State who engage in parallel exports to other Member States where prices for medicines are higher does not, generally speaking, constitute an abuse.
V tem okviru je treba preučiti, če obstajajo, kot to trdi GSK AEVE, v sektorju farmacevtskih proizvodov posebne okoli�čine, na podlagi katerih zavrnitev podjetja s prevladujočim položajem, da dobavlja v določeni državi članici strankam, ki opravljajo vzporedni izvoz v druge države članice, kjer so cene zdravil vi�je, na splo�no ne pomeni zlorabe.

In the light of the abovementioned Treaty objective as well as that of ensuring that competition in the internal market is not distorted, there can be no escape from the prohibition laid down in Article 82 EC for the practices of an undertaking in a dominant position which are aimed at avoiding all parallel exports from a Member State to other Member States, practices which, by partitioning the national markets, neutralise the benefits of ef-fective competition in terms of the supply.
Z vidika omenjenega cilja Pogodbe in cilja, na podlagi katerega ne sme priti do izkrivljanja konkurence na notranjem trgu, se tej prepovedi iz člena 82 ES prav tako ne morejo izogniti prakse podjetja s prevladujočim položajem, s katerimi se sku�a izogniti vsem vzporednim izvozom iz države članice v drugo državo članico, in sicer so to prakse, ki z deljenjem nacionalnih trgov nevtralizirajo koristi učinkovite konkurence v smislu oskrbe in cen.

In short, the Commercial Solvents and United Brands cases show that a dominant undertaking which avoids supplying goods, particularly when there are no substitutes, as in the case of Lamictal, and reserves to itself the parallel export market, is committing an abuse under Article 82 EC.
Skratka, iz sodb Commercial Solvents in United Brands je mogoče sklepati, da prevladujoče podjetje, ki ustavi oskrbo, zlasti če ne obstajajo alternativni proizvodi, kot v primeru zdravila Lamictal, in si pridrži trg vzporednega izvoza, zlorablja položaj v smislu člena 82 ES.

Each distributor was obliged to prevent exports from its territory to another through unofficial distribution channels(so-called parallel trade). Under Nintendo's leadership, the companies collaborated intensively to find the source of any such exports..
Vsak distributer je bil dolžan preprečiti izvoz s svojega na drugo ozemlje po neuradnih distribucijskih kanalih(tako imenovana vzporedna trgovina). Pod vodstvom Nintenda so podjetja intenzivno sodelovala, da bi ugotovila izvor vsakega takega izvoza..

We need to take this opportunity to deliver a comprehensive outcome tackling in parallel all forms of export support.
To priložnost moramo izkoristiti za dosego celovite rešitve, ki vzporedno zajema vse oblike izvozne podpore.

In the context of the DDA commitment on parallel elimination of all forms of export subsidies, the EC envisages eliminating export refunds on agricultural and food products.
V okviru zavez iz Razvojne agende iz Dohe o vzporedni odpravi vseh oblik izvoznih subvencij predvideva ES odpravo izvoznih nadomestil za kmetijske in živilske proizvode.

SDT02b- correct and prevent trade restrictions and distortions in world agricultural markets including by the parallel elimination of all forms of agricultural export subsidies and all export measures with equivalent effect, in accordance with the mandate of the Doha Development Round.
B Odpraviti in preprečevati trgovinske omejitve in izkrivljanje trgovine na svetovnih kmetijskih trgih, tudi z vzporedno odpravo vseh oblik kmetijskih izvoznih subvencij in izvoznih ukrepov z enakim učinkom, v skladu s pooblastili kroga pogajanj iz Dohe.

Calls on WTO members to correct and prevent trade restrictions and distortions in world agricultural markets, including through the parallel elimination of all forms of agricultural export subsidies and disciplines on all export measures with equivalent effect.
B Odpraviti in preprečevati trgovinske omejitve in izkrivljanje trgovine na svetovnih kmetijskih trgih, tudi z vzporedno odpravo vseh oblik kmetijskih izvoznih subvencij in izvoznih ukrepov z enakim učinkom.